Test Price
2,800 AED✅ Home Collection Available
SDHD Gene Carcinoid Tumor (Intestinal) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
SDHD Next‑Generation Sequencing delivers 99.9% diagnostic sensitivity for hereditary intestinal carcinoid tumors, processed in an ISO‑certified facility. VIP Mobile Phlebotomy home collection available daily from 8 AM to 11 PM across all Emirates with temperature‑controlled cold‑chain transport. Post‑test telephonic clinical guidance included. Direct insurance billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SDHD gene test screens for inherited mutations that predispose individuals to intestinal carcinoid tumours and paragangliomas, enabling early surveillance and family risk assessment. This NGS‑based analysis covers the entire coding region, providing unmatched precision compared to targeted genotyping.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity via ISO‑accredited NGS | Sanger sequencing (lower sensitivity for mosaicism) |
| Methodology | Next‑Generation Sequencing (Illumina) + Sanger confirmation | Single‑gene PCR/Sequencing |
| Turnaround | 3–4 Weeks (includes genetic counsellor report) | 4–6 Weeks, often without interpretive support |
Physician Insight & Safety Protocols
"This NGS panel identifies germline SDHD variants that strongly correlate with hereditary carcinoid syndrome. Clinical correlation with imaging and a detailed family history is essential to determine penetrance and guide prophylactic measures. I strongly encourage patients to review results with a certified genetic counsellor before making any medical decisions."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠️ Important: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Allogenic bone marrow transplant within the last 6 months (donor DNA interference).
- Exclusion: Active haematological malignancy with circulating tumour DNA >5% may obscure germline results.
- Emergency: Sudden severe abdominal pain, intense flushing, or rapid heartbeat – seek immediate medical attention, as these could indicate a carcinoid crisis.
Patient FAQ & Clinical Guidance
1. What is the SDHD gene and its connection to intestinal carcinoid tumours?
The SDHD gene encodes a subunit of the succinate dehydrogenase complex. Inherited mutations disrupt mitochondrial tumour suppression, leading to neuroendocrine tumours such as intestinal carcinoids. Early identification enables proactive surveillance for at‑risk family members.
2. How is the test performed and what sample is required?
A single blood draw, buccal swab, or one drop of blood on an FTA card provides sufficient DNA. We then perform next‑generation sequencing to analyse all SDHD exons for pathogenic variants. VIP Mobile Phlebotomy home collection is available daily from 8 AM to 11 PM with cold‑chain transport.
3. How long do results take and what is the cost?
Standard reporting time is 3 to 4 weeks at 2800 AED, inclusive of a genetic counselling summary. Home sample collection across the UAE is available from 8 AM to 11 PM daily. Insurance billing verification can be arranged via WhatsApp +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and processed under strict confidentiality protocols. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | SDHD Gene Sequencing (Intestinal Carcinoid) |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, buccal swab, or FTA card |
| Methodology Used | Next‑Generation Sequencing (Illumina) with Sanger confirmation |
| ICD-10-CM Code | C7A.0 (Malignant carcinoid tumors of the small intestine), C7A.1 (Malignant carcinoid tumors of the appendix), C7A.2 (Malignant carcinoid tumors of the colon) – Use as clinically indicated |
| LOINC Code | 81247-9 (SDHD gene mutation analysis in Blood or Tissue by NGS) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians